Convalescent plasma does not reduce mortality, disease progression in COVID-19
03 Nov 2020
byStephen Padilla
During the earliest days of the novel coronavirus disease (COVID-19) pandemic, convalescent plasma has generated great enthusiasm for its potential in treating the disease, but a recent study shows that its use does not lead to reduction in progression to severe COVID-19 or all-cause mortality.
Convalescent plasma does not reduce mortality, disease progression in COVID-19
03 Nov 2020
